Efficacy and Safety of Glimepiride as Oral Anti-Diabetic (OAD) Initiation Mono-therapy in Chinese Type 2 Diabetes Mellitus (T2DM)

Addition of Omarigliptin (MK-3102) to Participants With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Combination Therapy With Glimepiride and Metformin (MK-3102-022)

NCT01704261 ·Status: COMPLETED ·Phase: PHASE3

A Study of the Safety and Efficacy of Omarigliptin (MK-3102) Compared With Glimepiride in Participants With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin (MK-3102-016)

NCT01682759 ·Status: COMPLETED ·Phase: PHASE3

Effect of Oral Combination Therapy in a Single Dosage Form in Patients With Type 2 Diabetes Mellitus

NCT00941161 ·Status: COMPLETED ·Phase: PHASE4

A Study to Evaluate the Safety, Tolerability, and Efficacy of the Addition of Omarigliptin (MK-3102) to Participants With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Metformin Therapy (MK-3102-024)

NCT01755156 ·Status: COMPLETED ·Phase: PHASE3

Dose Proportionality Study Comparing Amaryl-M 1/500 mg and Amaryl-M 2/500 mg

NCT00934817 ·Status: COMPLETED ·Phase: PHASE1

Efficacy and Safety Comparison of Metformin/Glimepiride Combination Versus Each Compound Alone in New Diagnosed Type 2 Diabetes Patients

NCT01459809 ·Status: COMPLETED ·Phase: PHASE3

Efficacy and Safety of Repaglinide and Metformin Combination Therapy in Type 2 Diabetes Failing on Oral Anti-diabetic Drugs

NCT00491725 ·Status: COMPLETED ·Phase: PHASE4

Comparative Study of HOE490 O (Glimepiride and Metformin) Compared With Placebo on Top of Glimepiride

NCT00924573 ·Status: COMPLETED ·Phase: PHASE3

Efficacy/Safety Study of Glimepiride to Type 2 Diabetes Patients Based on Metformin And Basal Insulin Treatment

NCT02026310 ·Status: COMPLETED ·Phase: NA

Study To Understand Efficacy And Safety Of Investigational Agent (PF-04937319) Compared To Approved Agent (Glimepiride) In Patients With Diabetes On Metformin

NCT01517373 ·Status: COMPLETED ·Phase: PHASE2

A Glycemic Control Evaluation of Glimepiride Versus Rimonabant on Top of Metformin in Type 2 Diabetes

NCT00449605 ·Status: TERMINATED ·Phase: PHASE3

A Study to Evaluate the Safety and Efficacy of Omarigliptin (MK-3102) Compared With Glimepiride in Participants With Type 2 Diabetes Mellitus for Whom Metformin is Inappropriate (MK-3102-027)

NCT01863667 ·Status: TERMINATED ·Phase: PHASE3

Comparison of the Blood Sugar Lowering Effect Between Repaglinide Plus Metformin and Repaglinide Alone in Type 2 Diabetics Not Previously Treated With Oral Sugar-lowering Drugs

NCT00819741 ·Status: COMPLETED ·Phase: PHASE4

A Study of the Safety and Efficacy of Omarigliptin (MK-3102) in ≥18 and <45 Year-Old Participants With Type 2 Diabetes Mellitus and Inadequate Glycemic Control (MK-3102-028)

NCT01814748 ·Status: COMPLETED ·Phase: PHASE3

Effect of Rimonabant and Metformin Combination on Glycemic Control in Patients With Type 2 Diabetes

NCT00690456 ·Status: TERMINATED ·Phase: PHASE3

Initiation and Titration of Amaryl

NCT01144728 ·Status: COMPLETED ·Phase: PHASE4

Efficacy and Safety of Gemigliptin 50mg qd Added in Patients With Type 2 Diabetes Inadequately Controlled on Glimepiride and Metformin

NCT01990469 ·Status: COMPLETED ·Phase: PHASE3

Bioequivalence Study of 4 mg Glimepiride Tablet

NCT01677247 ·Status: COMPLETED ·Phase: NA

A Comparison of SLx-4090 in Combination With Metformin Versus Metformin Therapy Alone in Patients With Type 2 Diabetes

NCT00871936 ·Status: COMPLETED ·Phase: PHASE2

Dose Proportionality Study About Amaryl M Slow Release (SR) 1/500 mg

NCT00934323 ·Status: COMPLETED ·Phase: PHASE1

COMPOUND (INN): HOE490O - GLIMEPIRIDE / METFORMIN HCl (Amaryl® M)0 (Glimepiride/Metformin Hydrochloride Immediate Release Combination Tablet) in Fed Conditions in Healthy Male and/or Female Subjects.

NCT02395237 ·Status: WITHDRAWN ·Phase: PHASE1

Effect of Liraglutide or Glimepiride Added to Metformin on Blood Glucose Control in Subjects With Type 2 Diabetes

NCT00614120 ·Status: COMPLETED ·Phase: PHASE3

Efficacy and Safety of Repaglinide, Glurenorm® and Glucobay® in Chinese Subjects With Type 2 Diabetes

NCT00568074 ·Status: COMPLETED ·Phase: PHASE4

Phase 3 Study to Evaluate the Efficacy and Safety of ORMD-0801 in Subjects With Type 2 Diabetes Mellitus

NCT04817215 ·Status: UNKNOWN ·Phase: PHASE3

Continuous Glucose Monitoring System (CGMS) in Type 2 Diabetic Patients Inadequately Controlled by Metformine Monotherapy; Analyze of Glycemic Profile Before and After Association of Glimepiride

NCT00633425 ·Status: COMPLETED ·Phase: PHASE4